Skip to main content
Sign In
 

Sanjana Mehrotra, MD – PGY VI

Cytopathology Fellow


Education:​

 – MBBS; Topiwala National Medical College, Mumbai, India (2001)

 

Postdoctoral Education:

 – AP/CP Residency; Baystate Regional Medical Center/Tufts University, Springfield, MA (2011)

 – Transfusion Medicine Fellowship, University of Colorado Denver (2012)

 

Subspecialty:

 – Cytopathology Fellowship

 

Research Interests:​

 – 

 – 

 

 

Research Fellow, Indiana University Purdue University, Indianapolis, IN, (2003–2005)

NIH granted project: Retrospective analysis by immunohistochemistry of various cyclooxygenase and prostaglandin receptors in breast cancer; VEGF, CD31 study; Optimization of NF-kappa B immunohistochemical stain in mice tissue with injected cell lines.

 

Selected Publications:

 – 

 

 

 – 

 

 – 

 

 

Miller KD, Miller M, Mehrotra S, Agarwal B, Mock B, Zheng Qi-Huang, Badve S, Hutchins GD, Sledge GW Jr: A physiologic imaging polit study breast cancer treated with AZD2171. Clin Cancer Res. 2006 Jan 1;12(1):281-8.

Mehrotra S, Mormiya A, Agarwal B, Konger R, Badve S: Microsomal Prostaglandin E2 synthase-1 in breast cancer, a potential target for therapy. J Pathol. 2006 Feb;208(3):356-63.

Sweeney CJ, Mehrotra S, Sadraria MR, Kumar S, Shortle SH, Roman Y, Sheridan C, Campbell RA, Murry DJ, Badve S, Nakshatri H: The sesquiterpene lactone parthenolide in combination with docetaxel reduced metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther. 2005 Jun; 4(6):1004-12.

 

Contacts:

 Email:

 Pager:

Sanjana.Mehrotra@ucdenver.edu

(303) 266-3392

​​​​​​​